Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/34th-international-conference-pharmacoepidemiology-and	34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management	Sentinel Initiative Events	08/21/2018	34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Sentinel Initiative Events 08/21/2018
https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation	COVID-19 Pregnancy Study Implementation	Methods, Data, & Tools	02/24/2021	COVID-19 Pregnancy Study Implementation Methods, Data, & Tools 02/24/2021
https://sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-food-and	A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System	Publications and Presentations	04/18/2021	A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System Publications and Presentations 04/18/2021
https://sentinelinitiative.org/news-events/publications-presentations/strategies-use-real-world-data-conduct-covid-19-related	Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology	Publications and Presentations	08/25/2021	Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology Publications and Presentations 08/25/2021
https://sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel	Methods, Data, & Tools	03/16/2022	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel Methods, Data, & Tools 03/16/2022
https://sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroids-covid-19-us-outpatient-settings	Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings	Publications and Presentations	08/28/2022	Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings Publications and Presentations 08/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-patients-and-encounters-trinetx-live-usa	Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis	Analyses	01/12/2023	Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis Analyses 01/12/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-or-linked-infant	Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis	Analyses	03/03/2023	Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses 03/03/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-records-following	Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis	Analyses	03/03/2023	Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses 03/03/2023
https://sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz	Zarxio (Filgrastim-sndz) & Signal Identification	Studies	06/01/2023	Zarxio (Filgrastim-sndz) & Signal Identification Studies 06/01/2023
https://sentinelinitiative.org/news-events/publications-presentations/treatment-and-care-received-children-hospitalized-covid-19	Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021	Publications and Presentations	07/11/2023	Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021 Publications and Presentations 07/11/2023
https://sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us	High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network	Publications and Presentations	08/25/2023	High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network Publications and Presentations 08/25/2023
https://sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles	Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic	Publications and Presentations	08/27/2023	Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic Publications and Presentations 08/27/2023
https://sentinelinitiative.org/news-events/publications-presentations/unexpected-issues-pharmacoepidemiology-studies-applying	Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes	Publications and Presentations	10/17/2023	Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes Publications and Presentations 10/17/2023
https://sentinelinitiative.org/studies/drugs/ozempic-semaglutide	Ozempic (Semaglutide) & Signal Identification	Studies	10/25/2023	Ozempic (Semaglutide) & Signal Identification Studies 10/25/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-cardiac-congenital-malformations-following	Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis	Analyses	11/13/2023	Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Analyses 11/13/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/medication-use-among-pregnant-patients-covid-19-descriptive	Medication Use Among Pregnant Patients With COVID-19: A Descriptive Analysis	Analyses	01/11/2024	Medication Use Among Pregnant Patients With COVID-19: A Descriptive Analysis Analyses 01/11/2024
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Signal Identification	Studies	03/18/2024	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Signal Identification Studies 03/18/2024
https://sentinelinitiative.org/studies/drugs/new-onset-cancer	New-Onset Cancer & Duration of Follow-up	Studies	03/22/2024	New-Onset Cancer & Duration of Follow-up Studies 03/22/2024
https://sentinelinitiative.org/news-events/publications-presentations/validity-inpatient-electronic-health-record-based-measures	Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints	Publications and Presentations	04/02/2024	Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints Publications and Presentations 04/02/2024
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers-0	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization	Studies	06/13/2024	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization Studies 06/13/2024
https://sentinelinitiative.org/news-events/publications-presentations/use-sentinel-system-examine-medical-product-use-and-outcomes	Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy	Publications and Presentations	06/28/2024	Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy Publications and Presentations 06/28/2024
https://sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp	Brexafemme (Ibrexafungerp) & Use in Pregnancy	Studies	07/17/2024	Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies 07/17/2024
https://sentinelinitiative.org/studies/drugs/confounding-conditions	Confounding Conditions & Characterization	Studies	08/01/2024	Confounding Conditions & Characterization Studies 08/01/2024
https://sentinelinitiative.org/news-events/publications-presentations/comparing-risk-adverse-infant-outcomes-among-pregnancies-and	Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System	Publications and Presentations	08/27/2024	Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System Publications and Presentations 08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/prenatal-syphilis-us-characterizing-screening-and-treatment	Prenatal Syphilis in the US: Characterizing Screening and Treatment During Pregnancy in Publicly and Commercially Insured Individuals	Publications and Presentations	08/27/2024	Prenatal Syphilis in the US: Characterizing Screening and Treatment During Pregnancy in Publicly and Commercially Insured Individuals Publications and Presentations 08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-inpatient-electronic-health-records-ehr-large	Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States	Publications and Presentations	08/28/2024	Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States Publications and Presentations 08/28/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-prurigo-nodularis-and	Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis	Analyses	09/03/2024	Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis Analyses 09/03/2024
https://sentinelinitiative.org/studies/drugs/aldactone-spironolactone	Aldactone (spironolactone) & Indications for Use	Studies	10/15/2024	Aldactone (spironolactone) & Indications for Use Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/statins-tumor-necrosis-factor-tnf-alpha-inhibitors-granulocyte-colony-stimulating	Statins, Tumor Necrosis Factor (TNF) Alpha Inhibitors, Granulocyte Colony Stimulating Factors, Intravenous (IV) Iron, Beta Blockers, and Angiotensin-Converting Enzyme (ACE) Inhibitors & Utilization	Studies	10/15/2024	Statins, Tumor Necrosis Factor (TNF) Alpha Inhibitors, Granulocyte Colony Stimulating Factors, Intravenous (IV) Iron, Beta Blockers, and Angiotensin-Converting Enzyme (ACE) Inhibitors & Utilization Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/enterovirus	Enterovirus & Neonatal Enteroviral Sepsis	Studies	10/15/2024	Enterovirus & Neonatal Enteroviral Sepsis Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/hydroxyurea	Hydroxyurea & Use by Indication	Studies	10/15/2024	Hydroxyurea & Use by Indication Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/drugs-risk-evaluation-and-mitigation-strategies-rems-employ-elements-assure-safe-use	Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization	Studies	10/16/2024	Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization Studies 10/16/2024
https://sentinelinitiative.org/studies/drugs/her2-antagonists	HER2 Antagonists & Use in Pregnancy and Oligohydramnios	Studies	11/14/2024	HER2 Antagonists & Use in Pregnancy and Oligohydramnios Studies 11/14/2024
https://sentinelinitiative.org/studies/drugs/individuals-childbearing-potential	Individuals with Childbearing Potential & Conditions Prevalence	Studies	11/21/2024	Individuals with Childbearing Potential & Conditions Prevalence Studies 11/21/2024
https://sentinelinitiative.org/studies/drugs/sodium-glucose-co-transporter-2-sglt2-inhibitors-0	Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors & Cohort Characterization	Studies	11/27/2024	Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors & Cohort Characterization Studies 11/27/2024
https://sentinelinitiative.org/studies/drugs/covid-19-pregnancy	COVID-19 in Pregnancy & Drug Utilization, Disease Severity, Adverse Neonatal Outcomes, and Adverse Maternal Outcomes	Studies	12/31/2024	COVID-19 in Pregnancy & Drug Utilization, Disease Severity, Adverse Neonatal Outcomes, and Adverse Maternal Outcomes Studies 12/31/2024
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/cobenfy-xanomeline-tartrate-and	Assessment of ARIA Sufficiency: Cobenfy (xanomeline tartrate and trospium chloride)	Sufficiency Assessments	01/07/2025	Assessment of ARIA Sufficiency: Cobenfy (xanomeline tartrate and trospium chloride) Sufficiency Assessments 01/07/2025
https://sentinelinitiative.org/studies/drugs/dupixent-dupilumab	Dupixent (Dupilumab) & Signal Identification	Studies	01/13/2025	Dupixent (Dupilumab) & Signal Identification Studies 01/13/2025
https://sentinelinitiative.org/studies/drugs/individuals-prurigo-nodularis	Individuals with Prurigo Nodularis & Prevalence	Assessments	01/15/2025	Individuals with Prurigo Nodularis & Prevalence Assessments 01/15/2025